NeuBase Therapeutics, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)

3 Months Ended

Dec. 31, 2014

Schedule of assets and liabilities measured and recognized at fair value

The following table presents assets and liabilities that are measured and recognized at fair value as of December 31, 2014 and September 30, 2014, on a recurring basis:

Assets and liabilities measured at fair value on a recurring basis at December 31, 2014	Level 1	Level 2	Level 3		Total Carrying Value
Contingent Stock Consideration	$	$	$	5,560,745	$	5,560,745
	$	$	$	5,560,745	$	5,560,745

Assets and liabilities measured at fair value on a recurring basis at September 30, 2014	Level 1	Level 2	Level 3		Total Carrying Value
Contingent stock consideration	$	$	$	4,877,359	$	4,877,359
	$	$	$	4,877,359	$	4,877,359

Schedule of fair value of financial instruments by caption on balance sheet

The following tables present the change in fair value of financial instruments as of December 31, 2014, by caption on the balance sheet and by ASC 820 valuation hierarchy described above.

Level 3 Reconciliation:	Contingent Stock Contsideration
Total level 3 assets and liabilities at September 30, 2014		4,877,359
Purchases, sales, issuances and settlements (net)
Mark to market adjustments		683,386
Total level 3 assets and liabilities at December 31, 2014	$	5,560,745

- Definition

Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability.

+ References + Details